Literature DB >> 7049946

Natural history of aortic valve endocarditis in rats.

E Héraïef, M P Glauser, L R Freedman.   

Abstract

Sterile aortic vegetations were produced in rats by introducing a polyethylene catheter through the right carotid artery. The catheter was either left in place throughout the experiments or removed before bacterial challenge. Bacterial endocarditis was uniformly produced by intravenous injection of 10(7) colony-forming units of Staphylococcus aureus or Streptococcus intermedius, whether the catheter was left in place or removed. However, in rats with the catheter left in place, bacterial multiplication within the vegetations with both strains was accelerated, and mortality from Staphylococcus aureus infection was increased. Using 10(7) colony-forming units of serum-resistant Escherichia coli as a test microorganism, we found a marked difference in the production of endocarditis depending upon whether the catheter was left in place or removed before injection; only those animals infected with the catheter in place developed infection. From these experiments in rats, it was evident that the presence of a foreign body has a considerable influence on the ability of bacteria to grow within an intravascular vegetation. In addition, a striking difference in the virulence of the three strains studied was established; Staphylococcus aureus was the most, and E. coli the least, pathogenic.

Entities:  

Mesh:

Year:  1982        PMID: 7049946      PMCID: PMC347499          DOI: 10.1128/iai.37.1.127-131.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Chemotherapy of experimental streptococcal endocarditis. 3. Failure of a bacteriostatic agent (tetracycline) in prophylaxis.

Authors:  F S Southwick; D T Durack
Journal:  J Clin Pathol       Date:  1974-04       Impact factor: 3.411

2.  Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

3.  Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis.

Authors:  M A Sande; R G Irvin
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

4.  Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits.

Authors:  D T Durack; P B Beeson; R G Petersdorf
Journal:  Br J Exp Pathol       Date:  1973-04

5.  Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.

Authors:  D T Durack; R G Petersdorf
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

6.  Experimental bacterial endocarditis. I. Colonization of a sterile vegetation.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

7.  Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.

Authors:  D T Durack; L L Pelletier; R G Petersdorf
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

8.  Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.

Authors:  M A Sande; M L Johnson
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

9.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart.

Authors:  B B Perlman; L R Freedman
Journal:  Yale J Biol Med       Date:  1971-10

10.  Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart.

Authors:  P K Garrison; L R Freedman
Journal:  Yale J Biol Med       Date:  1970-06
View more
  59 in total

1.  Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus.

Authors:  J M Entenza; T J Foster; D Ni Eidhin; P Vaudaux; P Francioli; P Moreillon
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Invasion and killing of human endothelial cells by viridans group streptococci.

Authors:  Murray W Stinson; Susan Alder; Sarmishtha Kumar
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections.

Authors:  M Berti; G Candiani; M Borgonovi; P Landini; F Ripamonti; R Scotti; L Cavenaghi; M Denaro; B P Goldstein
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

4.  Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.

Authors:  J M Entenza; J Vouillamoz; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

5.  Guinea pig model for Staphylococcus aureus native valve endocarditis.

Authors:  M Maurin; H Lepidi; B La Scola; M Feuerstein; M Andre; J F Pellissier; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

6.  Contribution of sialic acid-binding adhesin to pathogenesis of experimental endocarditis caused by Streptococcus gordonii DL1.

Authors:  Yukihiro Takahashi; Eizo Takashima; Kisaki Shimazu; Hisao Yagishita; Takaaki Aoba; Kiyoshi Konishi
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

7.  Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains.

Authors:  Candice Rigoulay; José M Entenza; David Halpern; Eleonora Widmer; Philippe Moreillon; Isabelle Poquet; Alexandra Gruss
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.

Authors:  J M Entenza; Y A Que; J Vouillamoz; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis.

Authors:  P Moreillon; J M Entenza; P Francioli; D McDevitt; T J Foster; P François; P Vaudaux
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.

Authors:  Tiago Rafael Veloso; Aziz Chaouch; Thierry Roger; Marlyse Giddey; Jacques Vouillamoz; Paul Majcherczyk; Yok-Ai Que; Valentin Rousson; Philippe Moreillon; José Manuel Entenza
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.